Related Experiment Video
Updated: Jun 2, 2026
A Bedside, Single Burr Hole Approach to Multimodality Monitoring in Severe Brain Injury
Published on: March 26, 2019
[Verification of validity of MPM II for neurological patients in intensive care units]
1Department of Nursing, Namseoul University, Cheonan, Korea.
Purpose:
Mortality Probability Model (MPM) II is a model for predicting mortality probability of patients admitted to ICU. This study was done to test the validity of MPM II for critically ill neurological patients and to determine applicability of MPM II in predicting mortality of neurological ICU patients.
Methods:
Data were collected from medical records of 187 neurological patients over 18 yr of age who were admitted to the ICU of C University Hospital during the period from January 2008 to May 2009. Collected data were analyzed through χ(2) test, t-test, Mann-Whiteny test, goodness of fit test, and ROC curve.
Results:
As to mortality according to patients' general and clinically related characteristics, mortality was statistically significantly different for ICU stay, hospital stay, APACHE III score, APACHE predicted death rate, GCS, endotracheal intubation, and central venous catheter. Results of Hosmer-Lemeshow goodness-of-fit test were MPM II(0) (χ(2)=0.02, p=.989), MPM II(24) (χ(2)=0.99 p=.805), MPM II(48) (χ(2)=0.91, p=.822), and MPM II(72) (χ(2)=1.57, p=.457), and results of the discrimination test using the ROC curve were MPM II(0), .726 (p<.001), MPM II(24), .764 (p<.001), MPM II(48), .762 (p<.001), and MPM II(72), .809 (p<.001).
Conclusion:
MPM II was found to be a valid mortality prediction model for neurological ICU patients.
Insights
The Mortality Probability Model (MPM) II accurately predicts mortality in neurological ICU patients. This validated model aids in assessing outcomes for critically ill patients in intensive care units.
Area of Science:
- Critical Care Medicine
- Neurology
- Health Outcomes Research
Background:
- The Mortality Probability Model (MPM) II is a tool for predicting mortality in intensive care unit (ICU) patients.
- Evaluating the accuracy of existing predictive models in specific patient populations is crucial for clinical decision-making.
- Neurological patients represent a unique cohort with distinct physiological responses and outcomes in the ICU setting.
Purpose of the Study:
- To validate the Mortality Probability Model (MPM) II for critically ill neurological patients.
- To assess the applicability of the MPM II in predicting mortality specifically within neurological ICU populations.
- To determine the model's performance in a real-world clinical setting for neurological critical care.
Main Methods:
- Retrospective analysis of medical records from 187 adult neurological patients admitted to C University Hospital's ICU between January 2008 and May 2009.
- Statistical analysis included chi-squared tests, t-tests, Mann-Whitney tests, Hosmer-Lemeshow goodness-of-fit tests, and Receiver Operating Characteristic (ROC) curve analysis.
- Evaluation of MPM II's predictive accuracy at different time points (0, 24, 48, 72 hours post-admission).
Main Results:
- Mortality showed significant differences based on ICU stay, hospital stay, APACHE III score, predicted death rate, Glasgow Coma Scale (GCS), endotracheal intubation, and central venous catheter use.
- The Hosmer-Lemeshow goodness-of-fit tests indicated strong model fit for MPM II at all evaluated time points (p > 0.45).
- ROC curve analysis demonstrated significant discrimination capabilities for MPM II, with AUCs ranging from 0.726 to 0.809 (p < 0.001).
Conclusions:
- The Mortality Probability Model (MPM) II is a valid and applicable tool for predicting mortality in neurological ICU patients.
- The model's performance suggests its utility in risk stratification and outcome prediction for this specific patient group.
- Findings support the use of MPM II in clinical practice for neurological critical care management.
